Application 021493
- Type
- NDA
- Sponsor
- ALLERGAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ZYMAR | GATIFLOXACIN | SOLUTION/DROPS;OPHTHALMIC | 0.3% | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021493-001 | ZYMAR | GATIFLOXACIN | 0.3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION/DROPS / OPHTHALMIC | RLD | 2003-03-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N021493-001 | ZYMAR | 0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2003-03-28 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N021493-001 | ZYMAR | 0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2003-03-28 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N021493-001 | ZYMAR | 0.3% | SOLUTION/DROPS / OPHTHALMIC | RLD, RS | 2003-03-28 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N021493-001 | ZYMAR | 0.3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION/DROPS / OPHTHALMIC | RLD | 2003-03-28 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021493-001 | 6333045 | 2019-08-20 | Drug product, Delist requested | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021493-001 | 6333045*PED | 2020-02-20 | Pediatric extension | 74a2ff9319b5… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021493-001 | 6333045*PED | 2020-02-20 | Pediatric extension | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021493-001 | 6333045*PED | 2020-02-20 | Pediatric extension | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021493-001 | 6333045 | 2019-08-20 | Drug product, Delist requested | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021493-001 | 6333045*PED | 2020-02-20 | Pediatric extension | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021493-001 | 6333045 | 2019-08-20 | Drug product, Delist requested | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021493-001 | 6333045*PED | 2020-02-20 | Pediatric extension | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N021493-001 | 6333045 | 2019-08-20 | Drug product, Delist requested | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N021493-001 | 6333045*PED | 2020-02-20 | Pediatric extension | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GATIFLOXACIN | GATIFLOXACIN | Leading Pharma, LLC | 826cf8c4-4be5-4614-bd42-47c1d0c9df58 | 2025-10-28 | Warnings, Adverse reactions | GATIFLOXACIN |
| Gatifloxacin | GATIFLOXACIN | Sandoz Inc | 9e6fcd14-1fee-493f-811c-e18cbfbee65b | 2025-02-15 | Warnings, Adverse reactions | GATIFLOXACIN |
| ZYMAXID | GATIFLOXACIN | Allergan, Inc. | 1160b16c-929a-4e85-9c0b-1d8c96a7678b | 2016-09-08 | Warnings, Adverse reactions | GATIFLOXACIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 47683 | SUPPL | 2017-03-24 |
| 47632 | SUPPL | 2017-03-22 |
| 54221 | SUPPL | 2017-03-21 |
| 37070 | SUPPL | 2015-05-27 |
| 5542 | SUPPL | 2015-05-22 |
| 51933 | SUPPL | 2009-05-19 |
| 51932 | SUPPL | 2009-05-19 |
| 51931 | SUPPL | 2009-05-19 |
| 51930 | SUPPL | 2009-05-19 |
| 51929 | SUPPL | 2009-05-19 |
| 37069 | SUPPL | 2005-06-21 |
| 27929 | SUPPL | 2005-06-21 |
| 15599 | SUPPL | 2005-06-21 |
| 5541 | SUPPL | 2005-06-21 |
| 42192 | ORIG | 2005-05-02 |
| 37068 | ORIG | 2003-04-01 |
| 27928 | ORIG | 2003-04-01 |